Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $41,850 $41,850
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 350,000 379,615
Total Sell Value $0 $0 $5,692,673 $6,289,886
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 227
  Page 5 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-15 4 AS $27.53 $505,300 I/I (18,295) 5,147,534     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-14 4 AS $27.30 $1,248,129 I/I (45,719) 5,165,829     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-14 4 AS $27.30 $745,836 I/I (27,320) 3,152,090     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-14 4 AS $27.30 $745,836 I/I (27,320) 3,152,090     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-13 4 AS $27.13 $950,174 I/I (35,023) 5,211,548     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-13 4 AS $27.13 $567,804 I/I (20,929) 3,179,410     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-13 4 AS $27.13 $567,804 I/I (20,929) 3,179,410     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-12 4 AS $27.09 $386,303 I/I (14,260) 5,246,571     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-12 4 AS $27.09 $230,834 I/I (8,521) 3,200,339     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-12 4 AS $27.09 $230,834 I/I (8,521) 3,200,339     -
   Gall Matthew Chief Financial Officer   •       –      –    2021-10-11 4 OE $6.16 $88,883 D/D 14,429 19,429     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-11 4 AS $27.24 $2,225,072 I/I (81,684) 5,260,831     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-11 4 AS $27.24 $1,329,639 I/I (48,812) 3,208,860     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-11 4 AS $27.24 $1,329,639 I/I (48,812) 3,208,860     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-08 4 AS $27.01 $91,834 I/I (3,400) 5,342,515     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-08 4 AS $27.01 $54,884 I/I (2,032) 3,257,672     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-08 4 AS $27.01 $54,884 I/I (2,032) 3,257,672     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-07 4 AS $27.00 $51,894 I/I (1,922) 5,345,915     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-07 4 AS $27.00 $31,023 I/I (1,149) 3,259,704     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-07 4 AS $27.00 $31,023 I/I (1,149) 3,259,704     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-04 4 AS $27.06 $560,440 I/I (20,711) 3,260,853     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-04 4 AS $27.06 $937,873 I/I (34,659) 5,347,837     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-04 4 AS $27.06 $560,440 I/I (20,711) 3,260,853     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-10-01 4 AS $27.00 $185,085 I/I (6,855) 3,281,564     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-10-01 4 AS $27.00 $309,717 I/I (11,471) 5,382,496     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us